Mirae Asset Global Etfs Holdings Ltd. Replimune Group, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,352 shares of REPL stock, worth $432,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,352
Previous 37,699
17.65%
Holding current value
$432,432
Previous $456,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$108 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$106 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$47.8 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$46 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$38.1 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $481M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...